MX2022007457A - Metodos para tratar el coronavirus. - Google Patents

Metodos para tratar el coronavirus.

Info

Publication number
MX2022007457A
MX2022007457A MX2022007457A MX2022007457A MX2022007457A MX 2022007457 A MX2022007457 A MX 2022007457A MX 2022007457 A MX2022007457 A MX 2022007457A MX 2022007457 A MX2022007457 A MX 2022007457A MX 2022007457 A MX2022007457 A MX 2022007457A
Authority
MX
Mexico
Prior art keywords
methods
treating coronavirus
treating
tubulin
coronavirus
Prior art date
Application number
MX2022007457A
Other languages
English (en)
Inventor
Mitchell S Steiner
Kester Gary Barnette
Original Assignee
Veru Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veru Inc filed Critical Veru Inc
Publication of MX2022007457A publication Critical patent/MX2022007457A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se relaciona con los métodos de tratamiento de las infecciones por coronavirus utilizando compuestos que tienen actividad antitubulina o de disrupción de la tubulina.
MX2022007457A 2020-04-03 2021-04-05 Metodos para tratar el coronavirus. MX2022007457A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063004781P 2020-04-03 2020-04-03
US202163145886P 2021-02-04 2021-02-04
PCT/US2021/025807 WO2021203100A1 (en) 2020-04-03 2021-04-05 Methods of treating coronavirus

Publications (1)

Publication Number Publication Date
MX2022007457A true MX2022007457A (es) 2022-06-27

Family

ID=77920954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007457A MX2022007457A (es) 2020-04-03 2021-04-05 Metodos para tratar el coronavirus.

Country Status (14)

Country Link
US (1) US11648236B2 (es)
EP (1) EP4061349A4 (es)
JP (2) JP7460772B2 (es)
KR (1) KR20220110261A (es)
CN (1) CN115379835A (es)
AU (2) AU2021246118B2 (es)
BR (1) BR112022013480A2 (es)
CA (1) CA3166387A1 (es)
IL (1) IL293661A (es)
JO (1) JOP20220138A1 (es)
MX (1) MX2022007457A (es)
PE (1) PE20230413A1 (es)
WO (1) WO2021203100A1 (es)
ZA (1) ZA202206163B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024512816A (ja) * 2021-04-05 2024-03-19 ヴェル インコーポレイテッド 炎症を治療する方法
CN115504964A (zh) * 2022-04-12 2022-12-23 海创药业股份有限公司 氘代杂环酮类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006301222A1 (en) * 2005-10-14 2007-04-19 Neurosearch A/S Imidazole derivatives for the treatment of anxiety and related diseases
RU2581367C2 (ru) * 2010-03-01 2016-04-20 Джи Ти Икс, ИНК. Соединения для лечения рака
US20190389841A1 (en) * 2018-05-15 2019-12-26 University Of Tennessee Research Foundation Compounds for treatment of triple negative breast cancer and ovarian cancer

Also Published As

Publication number Publication date
KR20220110261A (ko) 2022-08-05
PE20230413A1 (es) 2023-03-07
EP4061349A4 (en) 2023-09-06
ZA202206163B (en) 2023-01-25
CA3166387A1 (en) 2021-10-07
AU2021246118B2 (en) 2024-03-28
BR112022013480A2 (pt) 2022-10-25
AU2021246118A1 (en) 2022-06-23
US11648236B2 (en) 2023-05-16
JP2023510719A (ja) 2023-03-15
IL293661A (en) 2022-08-01
WO2021203100A1 (en) 2021-10-07
US20210308105A1 (en) 2021-10-07
JP2024073625A (ja) 2024-05-29
JP7460772B2 (ja) 2024-04-02
CN115379835A (zh) 2022-11-22
AU2024202361A1 (en) 2024-05-02
WO2021203100A9 (en) 2021-12-23
JOP20220138A1 (ar) 2023-01-30
EP4061349A1 (en) 2022-09-28

Similar Documents

Publication Publication Date Title
CR20220642A (es) 2-oxoimidazolidin-4-carboxamidas como inhibidores de nav1.8
MX2022007376A (es) Fluoroalqull-oxadiazoles y sus usos.
MX2022007457A (es) Metodos para tratar el coronavirus.
MX2021016049A (es) Metodos de uso de inhibidores de rad51 para el tratamiento de cancer de pancreas.
WO2020021477A3 (en) Compositions and methods for treating the eye
WO2021158635A8 (en) Anti-viral compositions and methods of use
MX2022001019A (es) Amidas heterobiciclicas como inhibidoras del cumulo de diferenciacion 38 (cd38).
ZA202006612B (en) Antibacterial compounds
MX2022012386A (es) Compuestos inhibidores de metaloenzimas.
WO2022119858A8 (en) Compounds for the treatment of sars
CR20210474A (es) Compuestos de neuregulina-4 y métodos de uso
MX2022006109A (es) Derivados 1-aminosulfonil-2-carboxipirrol como inhibidores de metalo-beta-lactamasa.
MX2022000811A (es) Inhibidores de enzimas.
MX2023006651A (es) Tratamiento de la hemofilia con fitusirán.
MX2023005501A (es) Combinaciones de inhibidores de metap2 e inhibidores de cdk4/6 para el tratamiento de cáncer.
MX2022004270A (es) Inhibidores de aldosa reductasa para el tratamiento de la deficiencia de fosfomannomutasa 2.
WO2018125799A3 (en) Metalloenzyme inhibitor compounds
CR20230323A (es) Quinolinas y azaquinolinas como inhibidores de cd38
WO2022119854A8 (en) Compounds for the treatment of sars
MX2022016179A (es) Compuestos y metodos para tratar infecciones fungicas.
EP4146240A4 (en) METHODS OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION
MX2023004881A (es) Inhibidores de pde9 para el tratamiento de insuficiencia cardíaca.
WO2018058144A8 (en) Ship1 activator for treating prostatitis
MX2023005797A (es) Metodos de tratamiento de la insuficiencia hepatica.
MX2022011475A (es) Azd1656 para el uso en el tratamiento de neumonitis y/o la miocarditis causadas por un coronavirus.